← FDA DRUG APPROVALS

FDA ANDA · ANDA040845

BENZPHETAMINE HYDROCHLORIDE

Sponsor: IMPAX LABS

APPLICATION
ANDA040845
TYPE
ANDA
ORIGINAL APPROVAL
2008-11-18
LATEST ACTION
2020-12-29
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

BENZPHETAMINE HYDROCHLORIDEDiscontinued
BENZPHETAMINE HYDROCHLORIDE 50MG · TABLET · ORAL

Approval history

2020-12-29Labeling · Supplement 4 · standardAP
2010-04-27Labeling · Supplement 1AP
2008-11-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →